INVA Therapies Named Finalists for Prix Galien USA Award
Innoviva Specialty Therapeutics' XACDURO, ZEVTERA, and NUZOLVENCE are finalists for the Prix Galien USA Best Pharmaceutical Product Award
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.